$ALM

Almonty Industries: A 490-Million-Dollar Contract Offers Ballast as the Stock Tests Key Support

Almonty Industries’ shares fell to C$18.81, down 5.52% on Friday and about 44% below its April 52-week high, as the stock tests support near C$18.00. The company began processing at its Sangdong mine in South Korea and extended an offtake with Global Tungsten & Powders for 21 years, with higher volumes and prices, expected to add at least US$30m annual contract revenue and about US$490m total.

Original reporting
Published Jul 26, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 26, 2026, 5:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Almonty Industries: A 490-Million-Dollar Contract Offers Ballast as the Stock Tests Key Support — source image
Decision brief

The 30-second read

$ALMBullishMed
01

Why it matters

The expanded 21-year offtake with Global Tungsten & Powders increases committed volumes and prices, implying higher annual contract revenue and a large cumulative revenue stream, which can counterbalance technical weakness and insider selling.

02

Market read

Traders get a concrete fundamental catalyst (higher, longer offtake revenue visibility) while also needing to manage near-term technical and corporate-structure catalysts (support test, delisting dates, upcoming earnings).

03

What to watch

Delisting and ticker migration (Toronto and ASX to Nasdaq/Frankfurt) can distort technical levels and liquidity, making support tests less reliable than fundamentals alone.

Relevance 7/10Novelty 7/10Timing: ahead of the early-to-mid August quarterly earnings report, while ALM tests C$18 support.

Background

Almonty is transitioning from mine developer to active producer and is restructuring its listing footprint, while the stock has sold off sharply from its April peak.

Company-level read

Ticker impact

$ALMBullishMedium confidence
Context

Almonty extended and expanded its 21-year offtake with Global Tungsten & Powders, lifting committed volumes 40% and contract revenue by at least $30M annually.

Expected impact

Near-term stabilization bias; upside depends on whether Sangdong ramp and first concentrate timelines confirm the contract-driven revenue floor.

Evidence & confidence

The article provides specific contract terms (duration, volume increase, price increase) and quantifies incremental annual and lifetime revenue, which are direct fundamentals for ALM despite concurrent technical weakness and delisting logistics.

Market effects

Improved tungsten offtake terms for a producer can modestly reinforce confidence in long-cycle commodity cash flows, though it is company-specific rather than a sector-wide repricing.

Canadian and Australian holders face transfer timing around July 31 and Aug 28/Sept 1 delisting milestones, which can create localized liquidity and flow effects.

A 21-year tungsten supply commitment with higher volumes and prices may influence expectations for downstream tungsten supply stability, but the impact is limited to ALM’s counterparties and investors.

Counterpoint

The contract headline may not fully de-risk near-term execution risk because the article also highlights the producer transition and ramping at Sangdong, which can delay realized revenue.

Key entities

  • Almonty Industries

    Tungsten producer whose shares are testing C$18 support and whose offtake agreement was extended and expanded.

  • Global Tungsten & Powders

    Offtaker and member of Austria’s Plansee Group, whose agreement terms were improved (duration, volumes, pricing).

  • Plansee Group

    Parent group referenced as the owner of Global Tungsten & Powders.

  • Mark Trachuk

    Director who sold 200,000 shares on July 2, reducing his stake by 7.4%.

Related articles

$ALMMedAI 8/10

Almonty Industries Reports Second Quarter 2026 Financial Results

Almonty Industries (Nasdaq: ALM) reported Q2 2026 results: revenue rose 498% year over year to $43.0 million, with net income of $181.8 million and adjusted EBITDA of $17.6 million. The company closed an oversubscribed $800 million 2.25% convertible notes offering and reported $1.2 billion cash at June 30, 2026. It also amended its GTP offtake agreement, extending it 6 years and raising volumes and pricing.

$BMMMed

The Critical Metal at the Center of America’s Next Supply-Chain Crisis

The article says tungsten has outperformed gold, silver and copper over the past year and that the U.S. has not mined tungsten since 2015, while China supplies about 80% of global tungsten and nearly 90% of processing. It notes a U.S. defense rule from Jan 1, 2027 banning tungsten routed through China. It highlights Blue Moon Metals (TSXV: MOON, NASDAQ: BMM) acquiring 33 tungsten and antimony projects near its Springer complex, with consideration including 2.8M shares, $5.0M cash, and a 1% NSR r

$ALMMed

Almonty Industries Navigates a Pivotal Week: Production Milestones Meet Exchange Overhaul

Almonty Industries said it will delist from the Toronto Stock Exchange after July 31 and from the ASX after CHESS depositary interests end Aug. 28, with ASX delisting effective Sept. 1, citing low Australian volumes. Shares closed C$18.81, down 5.52% on Friday. Sangdong processing began July 1, and a 21-year offtake with Global Tungsten & Powders was expanded by 40% to about US$490 million potential revenue.

$ALMMed

Why is Almirall stock rallying today? By Investing.com

Almirall shares rose 3.5% to €11.45 after the company reported first-half 2026 results. EBITDA increased 23.7% year-on-year to €150.7 million and net sales rose 7.5% to €602.7 million, with biologics Ebglyss and Ilumetri driving growth. Management reiterated 2026 guidance (net sales +9–12%, EBITDA €270–290m). Net income slightly missed consensus.